Finance JournalistFinance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Ciena® Corporation (NYSE:CIEN) today announced its financial results for the fiscal fourth quarter and full year ended November 1, 2025.
For the fiscal fourth quarter of 2025, Ciena reported revenue of $1.35 billion, reflecting a 20% increase year-over-year.
For the full fiscal year 2025, the company generated $4.77 billion in revenue, marking a 19% year-over-year growth.
Zedge (NYSE:ZDGE) announced its financial results for the first quarter of fiscal 2026, ended October 31, 2025.
The company reported revenue of $7.6 million, reflecting a 5.8% year-over-year increase.
Save the Children has unveiled a first-of-its-kind Bitcoin (CRYPTO:BTC) Fund in partnership with digital asset firm Fortris to modernise humanitarian aid.
The fund allows the organisation to hold Bitcoin donations for up to four years under a “hodl” strategy to maximise long-term value.
OKYO Pharma (NASDAQ:OKYO) announced on December 11, 2025, new analyses from its Phase 2, placebo-controlled, randomized, double-masked trial of 0.05% urcosimod for the treatment of neuropathic corneal pain (NCP).
The trial, involving 18 patients, provided exploratory data on corneal nerve imaging using in vivo confocal microscopy.
Freight Technologies (NASDAQ:FRGT) reported its third-quarter results for the period ending September 30, 2025, highlighting key operational improvements as the company moves closer to a software- and AI-driven logistics model.
The company reduced its operating loss by $0.4 million in Q3 year-over-year and improved its year-to-date (YTD) operating loss by $1.2 million.
AI-enabled pharmaceutical company Algorae Pharmaceuticals (ASX:1AI) has received the comprehensive in silico synergy predictions generated by its AlgoraeOS v2 platform, covering over 500,000 potential combinations of cannabidiol with more than 3,000 approved and investigational drugs across 170 cell lines.
Australia's Treasurer Jim Chalmers has approved Hanwha's bid to lift its shareholding in Australian shipbuilder Austal (ASX:ASB) from 9.9% to 19.9%, concluding an eight-month Foreign Investment Review Board assessment.
Chalmers said the decision followed "long and careful deliberation" and extensive consultation, noting it took into account economic, national security and broader national-interest considerations.
The federal government has warned it will redirect a $23 billion hospital funding boost toward its own health priorities if states refuse the offer, amid escalating tensions over the National Disability Insurance Scheme and rising healthcare costs.
Prime Minister Anthony Albanese criticised Queensland Health Minister Tim Nicholls for publicly labeling the funding offer inadequate, saying the disclosure undermined efforts to negotiate in good faith.
